We are live on ! Find out more
AEMD icon

Aethlon Medical

11 hedge funds and large institutions have $604K invested in Aethlon Medical in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital inflows, than outflows

Capital inflows: $72.5K | Capital outflows: $67K

0.11% more ownership

Funds ownership: 3.07% → 3.18% (+0.11%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AEMD Hedge Fund Activity: Q2 2020 in Review

11 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2020, worth a combined $604K — up 38% from $437K a quarter earlier.

Fund positioning in AEMD was balanced in Q2 2020: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $24.2K. The largest seller was Ancora Advisors, exiting entirely with an estimated $46K sold.

  • 11 institutional investors held Aethlon Medical (AEMD) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $604K of Aethlon Medical stock for Q2 2020, up 38% quarter-over-quarter.
  • 3 funds opened new Aethlon Medical positions in Q2 2020 and 3 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q2 2020 was Geode Capital Management, an estimated $24.2K added.
  • The largest Aethlon Medical seller in Q2 2020 was Ancora Advisors, an estimated $46K sold.

Based on aggregated 13F filings for Q2 2020.